Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to empowering patients and healthcare providers with critical genetic insights. They discover, develop, and commercialize transformative molecular diagnostic tests that assess a person’s risk of developing disease, guide treatment decisions, and predict disease progression and recurrence across key clinical areas including oncology, women's health, and mental health.
The headquarters serves as the primary center for corporate leadership, strategic planning, research and development, and administrative operations supporting Myriad's global activities.
Located within the University of Utah Research Park, the facility benefits from proximity to academic research and a skilled talent pool. It houses state-of-the-art laboratories and modern office spaces conducive to scientific innovation.
Myriad Genetics fosters a work culture centered on scientific excellence, collaboration, and a patient-focused mission. Employees are typically driven by innovation and the impact of their work on advancing healthcare.
The Salt Lake City headquarters is central to Myriad's identity and operations, being the birthplace of the company and the hub for its pioneering research in genetic diagnostics.
Myriad Genetics primarily serves the United States market, with a significant and growing international presence, especially in Europe through its German subsidiary and lab in Planegg, near Munich. Globally, the company supports sales, marketing, laboratory testing services for certain products, research collaborations, and customer service to extend the reach of its genetic tests and precision medicine solutions to patients and healthcare providers internationally.
320 Wakara Way
Salt Lake City
UT
USA
Address: Lochhamer Str. 29A, 82152 Planegg, Germany
Facilitates Myriad's commercial operations and market presence in Europe, ensuring access to its diagnostic products for European healthcare providers and patients, and managing regional regulatory compliance.
Address: 180 Kimball Way, South San Francisco, CA 94080, USA
Drives innovation in specific genetic testing portfolios, supports West Coast operations, and contributes to Myriad's product development pipeline and market leadership in the U.S.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Myriad Genetics' leadership includes:
Myriad Genetics has been backed by several prominent investors over the years, including:
Over the past 12-18 months, Myriad Genetics has seen key leadership appointments aimed at bolstering its strategic priorities, particularly in Women's Health and commercial operations, alongside a significant transition in the Chief Operating Officer role.
Discover the tools Myriad Genetics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Myriad Genetics commonly utilizes an email format that combines the first initial of an employee's first name with their full last name, followed by the @myriad.com domain. Other formats may exist but this is a widely observed pattern.
[first_initial][last]@myriad.com
Format
jsmith@myriad.com
Example
85%
Success rate
Myriad Genetics Investor Relations • May 7, 2024
Myriad Genetics announced Q1 2024 revenue of $197.2 million, a 10% year-over-year increase, driven by strong performance in Oncology and Women’s Health. The company raised its full-year 2024 revenue and EPS guidance....more
GlobeNewswire via Myriad Genetics • April 16, 2024
Data from Myriad's FirstView registry indicated that its MyRisk Hereditary Cancer test with RiskScore (for all ancestries) identified significantly more women at high risk for breast cancer who could benefit from enhanced screening, compared to traditional clinical guidelines alone....more
Myriad Genetics Investor Relations • February 21, 2024
Myriad reported Q4 2023 revenue of $196.7 million and full-year 2023 revenue of $732.0 million (9% YoY growth). The company achieved positive adjusted EBITDA for the full year and expressed optimism for 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Myriad Genetics, are just a search away.